HomeATNM • NYSEAMERICAN
add
Actinium Pharmaceuticals Inc
Previous close
$8.15
Day range
$7.97 - $8.20
Year range
$4.00 - $10.24
Market cap
238.57M USD
Avg Volume
287.79K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 9.60M | -17.15% |
Net income | -8.67M | 21.45% |
Net profit margin | — | — |
Earnings per share | -0.31 | 27.91% |
EBITDA | -9.38M | 17.72% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 84.06M | -11.07% |
Total assets | 88.35M | -13.40% |
Total liabilities | 44.50M | -0.72% |
Total equity | 43.86M | — |
Shares outstanding | 29.78M | — |
Price to book | 5.47 | — |
Return on assets | -28.26% | — |
Return on capital | -56.90% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -8.67M | 21.45% |
Cash from operations | -7.37M | 51.09% |
Cash from investing | -11.00K | 85.53% |
Cash from financing | 14.77M | 1,817.92% |
Net change in cash | 7.38M | 151.33% |
Free cash flow | -4.59M | 57.95% |
About
CEO
Founded
2013
Website
Employees
49